Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.
about
Targeted Delivery of Proteasome Inhibitors to Somatostatin-Receptor-Expressing Cancer Cells by Octreotide ConjugationLoss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapsePositron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and TherapeuticsBombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice.Immunohistochemical localization of somatostatin receptors sst2A in human tumors.Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agentTreatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo resultsPeptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.Immunoelectronmicroscopic analysis of the ligand-induced internalization of the somatostatin receptor subtype 2 in cultured human glioma cells.Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.Encoding function into polypeptide-oligonucleotide precision biopolymers
P2860
Q27702302-CE7188F9-3CDE-4D58-A5FC-596C1DAAB3B0Q28540624-3F05D42A-8799-4F21-90B9-C3F43EFFEBDFQ34277286-ECC83AD8-2F05-4F9C-AB4E-6E1B3EDAF190Q34762840-D218CDED-F074-4D20-BB32-47901EB02B5AQ35057473-20406420-FC18-4BD7-938D-C07E93CA28ACQ35154082-146B9D2A-77FA-4C4E-A855-50CD66E12898Q35180952-085487A8-12E1-41B6-9378-EC08B019B5B4Q35753168-FBCC8E71-49DC-44A9-9D7B-C4A8D28FEB90Q36580521-9A3F8EA4-A013-4969-ADA1-8695CE8F6708Q36618155-CF7FEE79-D54E-4E97-8A11-01705CE126A4Q38965866-7B5C9721-04A8-4657-AE4D-06A536E9C563Q39763546-C143251E-4017-493F-A845-EEF6DF034DE6Q41002561-C5D15A8F-4ABF-4640-A512-100CA0941398Q41818303-1CC7F69D-DA78-481C-93AE-B906947302D2Q57035275-9826B379-804E-4D29-BF4D-1DDEF0FB90D7
P2860
Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Detection of somatostatin rece ...... dence for SSTR2 heterogeneity.
@en
type
label
Detection of somatostatin rece ...... dence for SSTR2 heterogeneity.
@en
prefLabel
Detection of somatostatin rece ...... dence for SSTR2 heterogeneity.
@en
P2093
P1433
P1476
Detection of somatostatin rece ...... dence for SSTR2 heterogeneity.
@en
P2093
Bashirzadeh R
Theveniau MA
P304
P356
10.1016/0196-9781(94)90146-5
P577
1994-01-01T00:00:00Z